Brief: Benitec Provides Positive Regulatory Updates For BB-301 Development Program

Benitec Biopharma

08/09/2021 13:48

Sept 8 (Reuters) - Benitec Biopharma Inc  BNTC.O :
    * BENITEC BIOPHARMA PROVIDES POSITIVE REGULATORY UPDATES FOR
BB-301 DEVELOPMENT PROGRAM; BB-301 PHASE 1B/2A CLINICAL TRIAL TO
BEGIN IN 2022

Source text for Eikon:  ID:nPn6h7g2Ka 
Further company coverage:  BNTC.O 

 ((Reuters.Briefs@thomsonreuters.com;))